Protalix Biotherapeutics (PLX)

Protalix (PLX) Financial Statements


Protalix Financial Overview

Protalix's market cap is currently ―. The company's EPS TTM is $0.022; its P/E ratio is 52.89; Protalix is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 10.49M$ 10.35M$ 35.08M$ 9.59M-
Gross Profit$ 1.63M$ 5.45M$ 35.08M$ 6.50M-
EBIT$ -5.65M$ -1.72M$ 19.65M$ -2.94M-
EBITDA$ -5.34M$ -1.35M-$ -2.58M-
Net Income Common Stockholders$ -6.04M$ -1.85M$ 19.34M$ -3.13M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.63M$ 20.41M$ 48.18M$ 33.04M$ 17.11M
Total Assets$ 84.43M$ 87.57M$ 88.42M$ 66.56M$ 55.79M
Total Debt$ 26.28M$ 26.01M$ 25.97M$ 33.57M$ 33.47M
Net Debt$ 2.65M$ 5.60M$ -22.21M$ 532.00K$ 16.36M
Total Liabilities$ 50.87M$ 49.32M$ 49.42M$ 65.55M$ 55.79M
Stockholders Equity$ 33.57M$ 38.25M$ 39.00M$ 1.01M$ -10.64M
Cash Flow-
Free Cash Flow$ 3.35M$ -7.33M-$ -3.25M-
Operating Cash Flow$ 3.60M$ -6.89M-$ -3.00M-
Investing Cash Flow$ -342.00K$ -20.88M-$ 4.73M-
Financing Cash Flow---$ 14.23M-
Currency in USD

Protalix Earnings and Revenue History

Protalix Debt to Assets

Protalix Cash Flow

Protalix Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis